BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38266462)

  • 1. Atypical chemokine receptors in cancer.
    Samus M; Rot A
    Cytokine; 2024 Apr; 176():156504. PubMed ID: 38266462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diverse and complex roles of atypical chemokine receptors in cancer: From molecular biology to clinical relevance and therapy.
    Sjöberg E; Meyrath M; Chevigné A; Östman A; Augsten M; Szpakowska M
    Adv Cancer Res; 2020; 145():99-138. PubMed ID: 32089166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond Cell Motility: The Expanding Roles of Chemokines and Their Receptors in Malignancy.
    Morein D; Erlichman N; Ben-Baruch A
    Front Immunol; 2020; 11():952. PubMed ID: 32582148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical chemokine receptors in tumor cell growth and metastasis.
    Lokeshwar BL; Kallifatidis G; Hoy JJ
    Adv Cancer Res; 2020; 145():1-27. PubMed ID: 32089162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical chemokine receptors 1, 2, 3 and 4: Expression and regulation in the endometrium during the estrous cycle and pregnancy and with somatic cell nucleus transfer-cloned embryos in pigs.
    Han J; Yoo I; Lee S; Jung W; Kim HJ; Hyun SH; Lee E; Ka H
    Theriogenology; 2019 Apr; 129():121-129. PubMed ID: 30844653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Atypical Chemokine Receptor Expression in T Cell Subsets.
    Pacheco MO; Rocha FA; Aloia TPA; Marti LC
    Cells; 2022 Dec; 11(24):. PubMed ID: 36552863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoluciferase-based methods to monitor activation, modulation and trafficking of atypical chemokine receptors.
    Luís R; D'Uonnolo G; Palmer CB; Meyrath M; Uchański T; Wantz M; Rogister B; Janji B; Chevigné A; Szpakowska M
    Methods Cell Biol; 2022; 169():279-294. PubMed ID: 35623707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New pairings and deorphanization among the atypical chemokine receptor family - physiological and clinical relevance.
    Szpakowska M; D'Uonnolo G; Luís R; Alonso Bartolomé A; Thelen M; Legler DF; Chevigné A
    Front Immunol; 2023; 14():1133394. PubMed ID: 37153591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atlas of the anatomical localization of atypical chemokine receptors in healthy mice.
    Melgrati S; Radice E; Ameti R; Hub E; Thelen S; Pelczar P; Jarrossay D; Rot A; Thelen M
    PLoS Biol; 2023 May; 21(5):e3002111. PubMed ID: 37159457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis of ACKR family members in breast cancer using prognostic values.
    Yang L; Zhang S; Pu P
    Oncol Lett; 2023 Oct; 26(4):425. PubMed ID: 37664667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical chemokine receptors: emerging therapeutic targets in cancer.
    Torphy RJ; Yee EJ; Schulick RD; Zhu Y
    Trends Pharmacol Sci; 2022 Dec; 43(12):1085-1097. PubMed ID: 36307250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of atypical chemokine receptor ACKR2 in experimental oral squamous cell carcinogenesis.
    da Silva JM; Dos Santos TPM; Saraiva AM; Fernandes de Oliveira AL; Garlet GP; Batista AC; de Mesquita RA; Russo RC; da Silva TA
    Cytokine; 2019 Jun; 118():160-167. PubMed ID: 29550065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACKR4 Recruits GRK3 Prior to β-Arrestins but Can Scavenge Chemokines in the Absence of β-Arrestins.
    Matti C; Salnikov A; Artinger M; D'Agostino G; Kindinger I; Uguccioni M; Thelen M; Legler DF
    Front Immunol; 2020; 11():720. PubMed ID: 32391018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Atypical Chemokine Receptors in Neuroinflammation and Neurodegenerative Disorders.
    Lindsay HG; Hendrix CJ; Gonzalez Murcia JD; Haynie C; Weber KS
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of conventional and atypical receptors for the chemokine CCL2 on mouse leukocytes.
    Ford LB; Cerovic V; Milling SW; Graham GJ; Hansell CA; Nibbs RJ
    J Immunol; 2014 Jul; 193(1):400-11. PubMed ID: 24890717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospects for targeting ACKR1 in cancer and other diseases.
    Crawford KS; Volkman BF
    Front Immunol; 2023; 14():1111960. PubMed ID: 37006247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adaptation and Constraint in the Atypical Chemokine Receptor Family in Mammals.
    Pan L; Lv J; Zhang Z; Zhang Y
    Biomed Res Int; 2018; 2018():9065181. PubMed ID: 30345310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging Roles of the Atypical Chemokine Receptor 3 (ACKR3) in Cardiovascular Diseases.
    Duval V; Alayrac P; Silvestre JS; Levoye A
    Front Endocrinol (Lausanne); 2022; 13():906586. PubMed ID: 35846294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical Chemokine Receptors in Cardiovascular Disease.
    Gencer S; van der Vorst EPC; Aslani M; Weber C; Döring Y; Duchene J
    Thromb Haemost; 2019 Apr; 119(4):534-541. PubMed ID: 30716778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biphasic Expression of Atypical Chemokine Receptor (ACKR) 2 and ACKR4 in Colorectal Neoplasms in Association with Histopathological Findings.
    Lewandowska P; Wierzbicki J; Zawadzki M; Agrawal A; Krzystek-Korpacka M
    Biomolecules; 2020 Dec; 11(1):. PubMed ID: 33374792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.